Danaher (DHR) to Release Earnings on Tuesday

Danaher (NYSE:DHR) is expected to post its Q1 2026 results before the market opens on Tuesday, April 21st. Analysts expect Danaher to post earnings of $1.94 per share and revenue of $6.0011 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, April 21, 2026 at 8:00 AM ET.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the company posted $2.14 EPS. Danaher’s quarterly revenue was up 4.6% on a year-over-year basis. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Stock Performance

Shares of DHR opened at $194.77 on Friday. The business’s 50 day moving average is $198.81 and its two-hundred day moving average is $214.79. Danaher has a 52-week low of $180.03 and a 52-week high of $242.80. The firm has a market cap of $137.84 billion, a price-to-earnings ratio of 38.64, a PEG ratio of 2.63 and a beta of 0.95. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio is currently 31.75%.

Analyst Upgrades and Downgrades

DHR has been the topic of several research analyst reports. The Goldman Sachs Group reduced their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Leerink Partners raised their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Robert W. Baird reduced their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, JPMorgan Chase & Co. raised their price objective on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $246.50.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 10.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Danaher

Several large investors have recently added to or reduced their stakes in DHR. Compound Planning Inc. increased its holdings in shares of Danaher by 47.1% during the fourth quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock valued at $2,187,000 after purchasing an additional 3,060 shares during the period. Invesco Ltd. increased its holdings in shares of Danaher by 8.1% during the fourth quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock valued at $943,201,000 after purchasing an additional 307,095 shares during the period. Birchwood Financial Partners Inc. acquired a new position in shares of Danaher during the fourth quarter valued at $41,000. Corient Private Wealth LLC increased its holdings in shares of Danaher by 2.0% during the fourth quarter. Corient Private Wealth LLC now owns 1,025,570 shares of the conglomerate’s stock valued at $228,812,000 after purchasing an additional 19,852 shares during the period. Finally, Alpine Woods Capital Investors LLC acquired a new position in shares of Danaher during the fourth quarter valued at $231,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.